Corcept Therapeutics Incorporated (CORT) — Capital Reinvestment Ratio
Corcept Therapeutics Incorporated (CORT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($38.45 Million) in capital expenditures ($50.00K). See cash generation quality of Corcept Therapeutics Incorporated to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Corcept Therapeutics Incorporated Capital Reinvestment Ratio (2015–2025)
This chart tracks Corcept Therapeutics Incorporated's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year Capital Reinvestment Ratio for Corcept Therapeutics Incorporated from 2015 to 2025. For live market cap and broader valuation context, see market value of Corcept Therapeutics Incorporated.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $142.00 Million | $211.00K | ▼ -86.4% |
| 2024 | 0.01x | $198.07 Million | $2.17 Million | ▲ +902.2% |
| 2023 | 0.00x | $127.04 Million | $139.00K | ▼ -68.1% |
| 2022 | 0.00x | $120.32 Million | $413.00K | ▲ +22.9% |
| 2021 | 0.00x | $167.89 Million | $469.00K | ▼ -65.7% |
| 2020 | 0.01x | $151.97 Million | $1.24 Million | ▲ +1.9% |
| 2019 | 0.01x | $136.12 Million | $1.09 Million | ▲ +210.2% |
| 2018 | 0.00x | $115.67 Million | $298.00K | ▼ -62.5% |
| 2017 | 0.01x | $60.94 Million | $419.00K | ▼ -34.8% |
| 2016 | 0.01x | $18.39 Million | $194.00K | ▲ +94.2% |
| 2015 | 0.01x | $3.13 Million | $17.00K | — |